To Evaluate the Efficacy of DDB/Garlic Oil in Patients With Elevated Transaminase Chronic Liver Disease
NCT02347319 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 262
Last updated 2015-01-27
Summary
Purpose
\- To evaluate the efficacy of Biphenyl dimethyl dicarboxylate(DDB)/Garlic Oil in patients with elevated transaminase chronic liver disease.
Conditions
Interventions
- DRUG
-
Pennel
Pennel 2 Tablet, Legalon Placebo 1 tablet, Tid
- DRUG
-
Legalon
Pennel Placebo 2 Tablet, Legalon 1 tablet, Tid
- DRUG
-
Pennel Placebo 2 Tablet, Legalon Placebo 1 tablet, Tid
Sponsors & Collaborators
-
PharmaKing
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-04-30
- Primary Completion
- 2013-05-31
- Completion
- 2013-06-30
Countries
- South Korea
Study Locations
More Related Trials
-
Study of Aldafermin (NGM282) in Participants With Impaired Hepatic Function
NCT04823702 ·Status: COMPLETED ·Phase: PHASE1
-
Cholic Acid for Hepatic Steatosis in Lipodystrophy
NCT00457639 ·Status: COMPLETED ·Phase: PHASE2
-
Polyunsaturated Fatty Acids in Patients With NAFLD.
NCT02647294 ·Status: COMPLETED ·Phase: NA
-
PBC Induced Fatigue Treated With Thiamine
NCT04893993 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Obeticholic Acid on Transport of Bile Acids in PBC Examined by 11C-cholyl-sarcosine PET/CT
NCT03253276 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effects of Carnitine Supplementation on Liver and Muscle
NCT03439917 ·Status: COMPLETED ·Phase: NA
-
Effect of Bezafibrate on Muscle Metabolism in Patients With Fatty Acid Oxidation Defects
NCT00983788 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Obeticholic Acid in Patients With Moderately Severe Alcoholic Hepatitis (AH)
NCT02039219 ·Status: TERMINATED ·Phase: PHASE2
-
The Effects of Synbiotics Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis
NCT01791959 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Phase I Trial of Silymarin for Chronic Liver Diseases
NCT00389376 ·Status: COMPLETED ·Phase: PHASE1
-
AST-120 Used to Treat Mild Hepatic Encephalopathy
NCT00867698 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis
NCT01473524 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Nigella Sativa on Nonalcoholic Steatohepatitis and Steatosis
NCT02307344 ·Status: UNKNOWN ·Phase: NA
-
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
NCT03073343 ·Status: RECRUITING ·Phase: NA
-
Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Participants With Primary Biliary Cirrhosis
NCT01865812 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect Of Dual Treatment With L-Carnitine And Magnesium On Fatty Liver
NCT01956825 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of S-adenosyl-L-methionine in Treatment of Chronic Hepatitis B Patients With Cholestasis
NCT01998620 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Polyphenol Supplementation on Hepatic Steatosis and Vascular Compliance
NCT03994029 ·Status: RECRUITING ·Phase: NA
-
High Oral Loading Dose of Cholecalciferol in Non-Alcoholic Fatty Liver Disease
NCT05578404 ·Status: COMPLETED ·Phase: PHASE2
-
Dietary Supplementation With Butyrate in Individuals With Liver Steatosis and Metabolic Syndrome
NCT06398522 ·Status: COMPLETED ·Phase: NA
-
Effects of FXR Activation on Hepatic Lipid and Glucose Metabolism
NCT00465751 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC)
NCT00570765 ·Status: COMPLETED ·Phase: PHASE2
-
Prebiotics in Patients With Non-alcoholic Liver Disease
NCT02642172 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial to Evaluate the Efficacy and Safety of 'URSA SOFT CAP. (UDCA-003)' in Fatigue Patients With Liver Dysfunction
NCT02415777 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Obeticholic Acid (OCA) Evaluating Pharmacokinetics and Safety in Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment
NCT03633227 ·Status: TERMINATED ·Phase: PHASE4